Press release
Sickle Cell Disease Treatment Market Opportunities and Forecasts, 2017 – 2025
Sickle Cell Disease Market: Market PlayersThe company already existing in the sickle cell disease treatment market are boosting their hematology pipeline by acquiring startups. Novartis is one such company who recently acquired Selexys Pharmaceuticals for USD 665 million. The deal is expected to help Novartis expand its product offerings as blood disease have high prices due to increasing demand.
Sickle cell disease is a genetic disorder and is the most common inherited genetic disorder. People with the sickle cell disease have abnormal shaped red blood cells that get blocked in the small blood vessels. This leads to a restricted flow of blood and oxygen in the body. Sickle cell disease is potentially a fatal disease as a patient may undergo vital organ failure, painful crisis, and other complications.
Sickle cell disease is broadly categorized as sickle cell disease, sickle cell disorder, and sickle cell anemia. The sickle cell disorder includes patient with positive sickle preparation smear. Sickle cell disease is where the patient faces serious morbidity such as vas-occlusive crises or organ failure. Sickle cell anemia is for patients who are homozygous for hemoglobin S.
Sickle Cell Disease Market: Dynamics
The main driver driving the sickle cell treatment market is the increasing number of new molecules in the pipeline and also the molecules which the government regulatory bodies are approving. Sickle cell disease treatment has given a new area of expansion for market players already in the sickle cell treatment market and for those who are trying to establish a new area in this market.
Modus therapeutics has been granted two U.S. patents for its drug Sevuparin, for the treatment of sickle cell disease. The molecule has been granted a patent for its manufacturing process and other for the treatment of sickle cell disease.
Moreover, researchers have moved ahead of treating sickle cell disease by antibiotics to the genome level. Researchers from Stanford School of Medicine successfully corrected the genes carrying the gene for sickle cell disease and transplanted those with healthy cells. By using the Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) technique, researchers replaced the sickle cell disease cell genes with the one which did not carry that gene.
The prenatal diagnosis using CVS has opened a window of opportunity for a couple expecting their child. The test gives information about the hemoglobin genotype of the unborn child. CVS and amniocentesis are both invasive procedure used for the identification of the presence of sickle cell disease DNA.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/16099
Sickle Cell Disease Market: Region-wise Outlook
North America dominated the sickle cell disease treatment market owing to the various insurance coverage policies and also the research undertakings by institutes and sickle cell treatment industry players. Medicare recently announced that it will cover most of the clinical trials which use stem cell transplantation for the treatment of sickle cell disease. Before the Medicare’s decision, adult patients found it difficult to use the chemo-free treatment as it was very expensive.
Apart from government support, the amount of approved treatment options for sickle cell disease is also increasing. The FDA recently accepted Emmaus Life Science NDA review for L-glutamine. Once accepted, this would be the first orally administered treatment option for children with sickle cell disease.
Asia-Pacific is the fastest growing region as various industry players funding for the stem cell research and also researchers bringing in new technologies for DNA analysis. Infosys donated
USD 1.11 million for stem cell research in India. The donation would be used for developing gene therapies for disorders such as sickle cell disease and hemophilia.
TOC Sentence Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/16099
Some of the sickle cell disease treatment providers are Gamida Cell, Biogen, Genetix Pharmaceuticals Inc., Alnylam Pharmaceuticals, Inc., Sangamo Biosciences, Acceleron Pharma, Global Blood Therapeutics Inc., Anthera, Mast Therapeutics, Inc. and Emmaus Medical, Inc.
To view complete report @http://www.persistencemarketresearch.com/market-research/sickle-cell-disease-treatment-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sickle Cell Disease Treatment Market Opportunities and Forecasts, 2017 – 2025 here
News-ID: 623469 • Views: …
More Releases from Persistence Market Research

Automotive Parts Aftermarket Outlook 2023-2033: Key Players Like Bosch, Denso, M …
The Automotive Parts Aftermarket has become a critical component of the global automotive ecosystem. According to Persistence Market Research, the market size reached US$ 548.5 billion in 2022 and is projected to expand to US$ 576.5 billion in 2023. With the replacement parts segment expected to achieve a total value of US$ 984.7 billion by 2033, the market is set to grow at a CAGR of 5.5% from 2023 to…

Centrifugal Pumps Market Set to Reach US$ 55.7 Billion by 2032, Insights from Pe …
The global centrifugal pumps market is poised for significant expansion, with the market projected to grow from US$ 41.2 billion in 2025 to reach US$ 55.7 billion by 2032, reflecting a CAGR of 4.4%. The growth is primarily fueled by increasing demand for efficient water management solutions across agriculture, industrial manufacturing, and municipal services. Centrifugal pumps play a crucial role in ensuring seamless fluid transfer, reducing energy consumption, and maintaining…

CAR T-cell Therapy Market to Touch US$24 Billion by 2032, Reports Persistence Ma …
The global CAR T-cell therapy market is experiencing transformative growth, projected to expand from an estimated US$5.8 billion in 2025 to US$24 billion by 2032, reflecting a compound annual growth rate (CAGR) of 25% during the forecast period from 2025 to 2032. This growth trajectory is being driven by a confluence of factors, including rising cancer prevalence, especially hematologic malignancies, and continuous advancements in gene-editing technologies and immunotherapy. As these…

Hydraulic Fluid Connector Market Technological Innovations, Efficiency Drivers, …
Hydraulic fluid connectors are used only in fluid power and piping systems for efficient operation in industrial fluid networks. A hydraulic fluid connector is deployed in these systems to increase the total machine performance irrespective of applications. Hydraulic fluid connectors are used to enhance uptime in the remote applications such as oil and gas drilling, pipeline installation and mining.
Innovations in the offering of tearout-proof technology for hydraulic…
More Releases for Sickle
Sickle Cell Disease Treatment Market - Improving Quality of Life: Pioneering Sic …
Newark, New Castle, USA: The "Sickle Cell Disease Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Sickle Cell Disease Treatment Market: https://www.growthplusreports.com/report/sickle-cell-disease-treatment-market/7808
This latest report researches the…
Sickle Cell Disease Treatment Market - Breaking the Chains of Sickle Cell: Pione …
Newark, New Castle, USA - new report, titled Sickle Cell Disease Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sickle Cell Disease Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sickle Cell Disease Treatment market. The report offers…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market is a segment of the broader pharmaceutical industry that is focused on developing treatments for sickle cell disease, a genetic disorder that affects the red blood cells. In 2022, the sickle cell disease treatment market is expected to continue to grow, driven by the increasing prevalence of the disease and the development of new treatments. The market is expected to be worth billions of…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the healthcare industry that produces and markets treatments for sickle cell disease (SCD), a genetic disorder that affects the production of hemoglobin in red blood cells. SCD can cause various complications, including pain, infections, and organ damage, and there is currently no cure for the disease. However, various treatments are available that can help manage the symptoms and improve…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The sickle cell disease treatment market refers to the segment of the pharmaceuticals industry that deals with the production and sales of treatments for sickle cell disease. Sickle cell disease is a genetic blood disorder that causes red blood cells to become misshapen and form a sickle shape. This can lead to a range of complications, including anemia, chronic pain, and increased risk of infections.
The market for sickle cell disease…
Global Sickle Cell Disease Treatment Market 2023: Sickle Cell Anaemia Anticipate …
The Sickle Cell Disease Treatment Market is an emerging segment in the healthcare industry. This debilitating disorder affects millions of people around the world, with no known cure available. However, recent advances in research have improved the treatment options for those suffering from sickle cell disease. The Sickle Cell Disease Treatment Market is expected to experience significant growth over the coming years as treatments become more effective and accessible. Several…